ECS Exclusive: How we pulled off the biggest cross-border pot deal in Aussie history
On Tuesday, northern Victorian quiet achiever – the medicinal cannabis cultivator and manufacturer ECS Botanics (ASX:ECS) – revealed it secured a stunning five-year, $24 million deal to supply Perth-based MediCann Health with its top (medicinal cannabis dried flower) strain. The deal builds on the existing two-year contract and expects to deliver over four tonnes of dried cannabis flower…
ECS Botanics (ASX:ECS) secures $9.9m cannabis supply agreement
ECS Botanics (ECS) has secured a $9.9 million supply agreement for medicinal cannabis products in Germany. The company entered a binding agreement with German company Ilios Santé GmbH for the supply of medicinal cannabis. Under the contract, ECS will exclusively supply four medicinal cannabis strains to Ilios Sante, with the first supply anticipated once product…
ECS Botanics talks green cannabis cultivation ahead of Peak Asset Management conference
ECS Botanics Holdings Ltd (ASX:ECS) managing director Nan-Maree Schoerie brings Proactive’s Elisha Newell up to speed on the company’s value proposition ahead of the Peak Asset Management Microcap Conference on Thursday, July 13
ECS Botanics (ASX:ECS) secures $11.9m to supply medicinal cannabis dried flower in Australia
ECS Botanics (ECS) has entered two offtake agreements worth a combined more than $11.9 million to supply medicinal cannabis dried flower in Australia. The company announced it will supply Melbourne-based Entoura with Good Manufacturing Practice (GMP) medicinal cannabis dried flower, worth $10.2 million over three years. Entoura supplies and develops high-quality medicinal cannabis products, but also…
ECS Botanics (ASX:ECS) frees up funds with asset sales and new debt facility
Medicinal cannabis company, ECS Botanics (ECS) has launched the sale of two assets and secured a new loan facility. The company agreed to sell its hemp food and wellness business for $250,000 to Ananda Food, with contract completion expected in August upon the finalisation of due diligence. In addition, the company has planned to sell its…
ECS Botanics (ASX:ECS) hands over Tasmanian assets to Blue Buffalo
ECS Botanics (ECS) has reached financial settlement of its Tasmanian medicinal cannabis business and assets for $3 million. The medicinal cannabis company agreed to sell its subsidiary, TasCo, which holds its Tasmanian operations and farm, to Blue Buffalo for $3 million. On October 24, the company announced to the market it had entered an unconditional…
Medicinal cannabis grower ECS Botanics locks in $24m supply deal with MediCann Health
Shares in ECS Botanics (ASX: ECS) rose by more than 22 per cent this morning after the Victorian medicinal cannabis grower and manufacturer announced its third supply contract win in just over three months, taking the total value of agreements reached since late June to $35.9 million.
ECS Botanics talks sustainable business model and positive quarterly cashflow
ECS Botanics Ltd (ASX:ECS) managing director Nan-Maree Schoerie tells Proactive the company is an Australian medicinal cannabis cultivator and manufacturer with operations in northwest Victoria.
ECS Botanics (ASX:ECS) reports 94pc increase in Dec quarterly revenue
ECS Botanics (ECS) has reported significant growth in its December quarter, achieving its key milestone of positive quarterly cashflow.
ECS delivers 450% PCP growth in Q3 revenue, targets UK and European giants as new frontiers for its homegrown cannabis
ECS Botanics has had another incredibly productive quarter, producing revenue of over $2m in Q3. And with the European majors opening up, the vertically integrated company says it’s in a great position with harvesting currently underway. Benchmark Aussie medicinal cannabis play ECS Botanics (ASX:ECS) has delivered more than $2million in revenue for the third quarter, as demand…
Cannabidiol: The ultimate investor’s guide to a potential $64 billion global market
Cannabis has been used as medicine for thousands of years. Ancient Indian, Chinese, and Egyptian civilisations have all employed it to cure various illnesses. But increasing recreational use and perceived harm to society meant that it has been outlawed in many countries since the early 20th century. In the US for example, cannabis was restricted…
Canngea attracted to ECS Botanics’ sustainably grown cannabis, inks deal
The company flagged additional revenue opportunities in the year ahead as it establishes traction as the leading B2B supplier in the Australian cannabis market as the supply agreement with Canngea finalised. Leading medicinal cannabis company ECS Botanics (ASX:ECS) continues to execute on a rapid growth trajectory, as it gains traction as the supplier of choice for a…
Akerna News: Women Are Consuming More Cannabis Every Year
In every sector of culture and society, a shift towards greater diversity is moving the needle on what, and who is considered “typical”. This is as true in the realm of cannabis consumption as anywhere else, with the stereotype of surfer dude stoners and glazed and confused couch potatoes making way for women as the…
